← Back to Search

Participants with gastric cancer for Stomach Cancer

N/A
Recruiting
Led By Monika Laszkowska, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 years
Awards & highlights

Study Summary

The purpose of this study is to create a registry of participants with precursor lesions for gastric cancer, including gastric atrophy, intestinal metaplasia, and dysplasia. Normal controls and individuals with gastric cancer for comparison of baseline characteristics will also be enrolled.

Eligible Conditions
  • Stomach Cancer
  • Gastric Atrophy
  • Gastric Intestinal Metaplasia
  • Dysplasia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Creation of participant registry

Side effects data

From 2019 Phase 2 trial • 60 Patients • NCT02060370
83%
Fatigue
76%
Diarrhea
61%
Platelet count decreased
58%
White blood cell decreased
54%
Mucositis oral
54%
Hand-foot syndrome
54%
Anemia
46%
Dysgeusia
44%
Nausea
41%
Rash
39%
Proteinuria
39%
Neutrophil count decreased
36%
Creatinine increased
32%
Aspartate aminotransferase increased
27%
Hypertension
25%
Hypothyroidism
24%
Vomiting
22%
Dyspepsia
20%
Hypoalbuminemia
20%
Anorexia
20%
Dyspnea
20%
Skin hypopigmentation
19%
Alanine aminotransferase increased
17%
Watering eyes
15%
Edema
14%
Weight loss
14%
Oral dysesthesia
14%
Epistaxis
14%
Pruritus
12%
Hyperglycemia
12%
Gastroesophageal reflux disease
12%
Lymphocyte count decreased
12%
Hypocalcemia
10%
Alkaline phosphatase increased
10%
Blood bilirubin increased
10%
Constipation
10%
Dysesthesia
10%
Headache
8%
Hyponatremia
8%
TSH increased
7%
Dry skin
7%
Anal mucositis
7%
Hypomagnesemia
7%
Hair hypopigmentation
7%
Myalgia
7%
Dry mouth
7%
Non-cardiac chest pain
7%
Paresthesia
5%
Alopecia
5%
Bloating
5%
Thromboembolic event
5%
CD4 lymphocytes decreased
5%
Hyperkalemia
5%
Thrombotic thrombocytopenic purpura
5%
Abdominal pain
5%
Hemoglobinuria
2%
Dehydration
2%
Vascular access complication
2%
Hypophosphatemia
2%
Gout
2%
Pancreatic insufficiency
2%
Urticaria
100%
80%
60%
40%
20%
0%
Study treatment Arm
Sunitinib

Trial Design

3Treatment groups
Experimental Treatment
Group I: Participants with gastric cancerExperimental Treatment1 Intervention
Participants with gastric cancer
Group II: Participants with atrophic gastritis, intestinal metaplasia, and dysplasiaExperimental Treatment1 Intervention
Participants with presence of atrophic gastritis, intestinal metaplasia, and dysplasia and risk of the progression of these lesions
Group III: Control GroupExperimental Treatment1 Intervention
Healthy controls
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Questionnaire
2014
Completed Phase 2
~20020

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,936 Previous Clinical Trials
585,698 Total Patients Enrolled
Monika Laszkowska, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Study Collecting Health Information to Understand and Prevent Gastric Cancer
2024. "A Study Collecting Health Information to Understand and Prevent Gastric Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06370143.
All > New York City > Philadelphia
~2133 spots leftby Apr 2036
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top